Quintos JB, Hodax JK, Gonzales-Ellis BA, Phornphutkul C, Wajnrajch MP, et al. Efficacy of growth hormone therapy in Kearns-Sayre syndrome: the KIGS experience. J Pediatr Endocrinol Metab 2016;29:1319–24.Google Scholar
Kang YX, Wang YJ, Zhang Q, Pang XH, Gu W. A case of hypopituitarism accompanying Kearns-Sayre syndrome treated with human chorionic gonadotropin: a case report and literature review. Andrologia 2016. doi: .CrossrefGoogle Scholar
Berio A, Piazzi A. Multiple endocrinopathies (growth hormone deficiency, autoimmune hypothyroidism and diabetes mellitus) in Kearns-Sayre syndrome. Pediatr Med Chir 2013;35:137–40.Google Scholar
Obara-Moszynska M, Maceluch J, Bobkowski W, Baszko A, Jaremba O, et al. A novel mitochondrial DNA deletion in a patient with Kearns-Sayre syndrome: a late-onset of the fatal cardiac conduction deficit and cardiomyopathy accompanying long-term rGH treatment. BMC Pediatr 2013;13:27.Google Scholar
Holloman CM, Wolfe LA, Gahl WA, Boerkoel CF. Kearns-Sayre syndrome presenting as isolated growth failure. BMJ Case Rep 2013;2013. pii: bcr2012007272.Google Scholar
Berio A, Piazzi A. Facial anomalies in a patient with cytochrome-oxidase deficiency and subsequent Kearns-Sayre syndrome with growth hormone deficiency. Minerva Med 2007;98:81–5.Google Scholar
De Sanctis V, Calzolari F, Piazzi A, Berio A. Kearns-Sayre syndrome associated with growth hormone deficiency. Pediatr Med Chir 2003;25:447–51.Google Scholar
Berio A, Piazzi A. Kearns-Sayre syndrome with GH deficiency. Pediatr Med Chir 2000;22:43–6.Google Scholar
Mohri I, Taniike M, Fujimura H, Matsuoka T, Inui K, et al. A case of Kearns-Sayre syndrome showing a constant proportion of deleted mitochondrial DNA in blood cells during 6 years of follow-up. J Neurol Sci 1998;158:106–9.Google Scholar
Eviatar L, Shanske S, Gauthier B, Abrams C, Maytal J, et al. Kearns-Sayre syndrome presenting as renal tubular acidosis. Neurology 1990;40:1761–3.Google Scholar
Burns EC, Preece MA, Cameron N, Tanner JM. Growth hormone deficiency in mitochondrial cytopathy. Acta Paediatr Scand 1982;71:693–7.Google Scholar
Egger J, Kendall BE. Computed tomography in mitochondrial cytopathy. Neuroradiology 1981;22:73–8.Google Scholar
O’Grady MJ, Monavari AA, Cotter M, Murphy NP. Sideroblastic anaemia and primary adrenal insufficiency due to a mitochondrial respiratory chain disorder in the absence of mtDNA deletion. BMJ Case Rep 2015;2015. pii: bcr2014208514.Google Scholar
Schwartzentruber J, Buhas D, Majewski J, Sasarman F, Papillon-Cavanagh S, et al. Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with Leigh syndrome. Hum Mutat 2014;35:1285–9.Google Scholar
Romano S, Samara D, Crosnier H, Valayannopoulos V, Polak M, et al. Variable outcome of growth hormone administration in respiratory chain deficiency. Mol Genet Metab 2008;93:195–9.Google Scholar
Cassandrini D, Savasta S, Bozzola M, Tessa A, Pedemonte M, et al. Mitochondrial DNA deletion in a child with mitochondrial encephalomyopathy, growth hormone deficiency, and hypoparathyroidism. J Child Neurol 2006;21:983–5.Google Scholar
Saneto RP, Bouldin A. A boy with muscle weakness, hypercarbia, and the mitochondrial DNA A3243G mutation. J Child Neurol 2006;21:77–9.Google Scholar
Barberi S, Bozzola E, Berardinelli A, Meazza C, Bozzola M. Long-term growth hormone therapy in mitochondrial cytopathy. Horm Res 2004;62:103–6.Google Scholar
Matsuzaki M, Izumi T, Shishikura K, Suzuki H, Hirayama Y. Hypothalamic growth hormone deficiency and supplementary GH therapy in two patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes. Neuropediatrics 2002;33:271–3.Google Scholar
Balestri P, Grosso S. Endocrine disorders in two sisters affected by MELAS syndrome. J Child Neurol 2000;15:755–8.Google Scholar
Gücüyener K, Seyrantepe V, Topaloğlu H, Ozgüç M. Mitochondrial deletion in a boy with growth hormone deficiency mimicking cerebral palsy. J Inherit Metab Dis 1998;21:173–4.Google Scholar
Yorifuji T, Kawai M, Momoi T, Sasaki H, Furusho K, et al. Nephropathy and growth hormone deficiency in a patient with mitochondrial tRNA(Leu(UUR)) mutation. J Med Genet 1996;33:621–2.Google Scholar
Niaudet P, Heidet L, Munnich A, Schmitz J, Bouissou F, et al. Deletion of the mitochondrial DNA in a case of de Toni-Debré-Fanconi syndrome and Pearson syndrome. Pediatr Nephrol 1994;8:164–8.Google Scholar
Yang CY, Lam HC, Lee HC, Wei YH, Lu CC, et al. MELAS syndrome associated with diabetes mellitus and hyperthyroidism: a case report from Taiwan. Clin Endocrinol (Oxf) 1995;43:235–9.Google Scholar
Chen XY, Zhao SY, Wang Y, Wang D, Dong CH, et al. A novel mitochondrial DNA deletion in a patient with Pearson syndrome and neonatal diabetes mellitus provides insight into disease etiology, severity and progression. Mitochondrial DNA A DNA Mapp Seq Anal 2016;27:2492–5.Google Scholar
About the article
Published Online: 2017-01-13
Published in Print: 2017-04-01
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: None declared.
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.